Table 1. IC50s of gefitinib and MK2206 for the NSCLC cell lines used in this study.
| Cell line | IC50 (μM ± SEM) | |
|---|---|---|
| gefitinib | MK2206 | |
| PC-9 | 0.07±8x10-2 | 1.18±0.23 |
| HCC-827 | 0.03±8x10-5 | 2.25±0.25 |
| A549 | 5.25±0.77 | 4.81±0.43 |
| H1975 | 9.57±1.94 | 7.66±0.63 |
| Cell line | IC50 (μM ± SEM) | |
|---|---|---|
| gefitinib | MK2206 | |
| PC-9 | 0.07±8x10-2 | 1.18±0.23 |
| HCC-827 | 0.03±8x10-5 | 2.25±0.25 |
| A549 | 5.25±0.77 | 4.81±0.43 |
| H1975 | 9.57±1.94 | 7.66±0.63 |